首页> 外文期刊>Orphanet journal of rare diseases >The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis
【24h】

The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis

机译:α 1 -抗胰蛋白酶缺乏与肺泡蛋白沉着症的平行寿命

获取原文
           

摘要

In 1963, five cases of alpha1-antitrypsin deficiency were reported in the scientific literature, as well as an attempt to treat pulmonary alveolar proteinosis by a massive washing of the lung (whole lung lavage). Now, fifty years later, it seems the ideal moment not only to commemorate these publications, but also to point out the influence both papers had in the following decades and how knowledge on these two fascinating rare respiratory disorders progressed over the years. This paper is therefore not aimed at being a comprehensive review for both disorders, but rather at comparing the evolution of alpha1-antitrypsin, a rare disorder, with that of pulmonary alveolar proteinosis, an ultra-rare disease. We wanted to emphasize how all stakeholders might contribute to the dissemination of the awareness of rare diseases, that need to be chaperoned from the ghetto of neglected disorders to the dignity of recognizable and treatable disorders.
机译:1963年,科学文献中报告了5例α1-抗胰蛋白酶缺乏症,并尝试通过大量洗净肺部(全肺灌洗)来治疗肺泡蛋白沉着症。现在,五十年后,似乎不仅是纪念这些出版物的理想时机,而且还指出了这两篇论文在接下来的几十年中产生的影响,以及多年来对这两种引人入胜的罕见呼吸系统疾病的了解是如何发展的。因此,本文的目的不是要对这两种疾病进行全面的综述,而是要比较一种罕见疾病α1-抗胰蛋白酶与一种极少见的疾病-肺泡蛋白沉着病的进化。我们想强调的是,所有利益相关者如何才能促进对稀有疾病的认识,这需要从被忽视的贫民区贫民区转移到可识别和可治疗的疾病的尊严。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号